2015
DOI: 10.1586/14737159.2015.1105133
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization

Abstract: Transcriptomic technologies are evolving to diagnose cancer earlier and more accurately to provide greater predictive and prognostic utility to oncologists and patients. Digital techniques such as RNA sequencing are replacing still-imaging techniques to provide more detailed analysis of the transcriptome and aberrant expression that causes oncogenesis, while companion diagnostics are developing to determine the likely effectiveness of targeted treatments. This article examines recent advancements in molecular … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(20 citation statements)
references
References 94 publications
0
19
0
Order By: Relevance
“…These class-specific estimates of RNA abundance indicate that ∼90% of the human transcriptome by mass is composed of rRNA, while the highest number of molecules per cell (MPC) is attributed to tRNA (Waldron and Lacroute 1975;Wolf and Schlessinger 1977). Other methods such as reverse transcription quantitative PCR (RT-qPCR) (Ginzinger 2002;Shakeel et al 2017), digital PCR (dPCR) (Whale et al 2012;Hayden et al 2013;Witwer et al 2013;Morley 2014;Sager et al 2015), and in situ hybridization (e.g., FISH) (Vera et al 2016) are also being used for RNA quantification, but their use remains limited to a relatively low number of RNAs and they are rarely utilized for comparisons between different classes of RNA. More recently, transcriptome sequencing has become the most frequently used method for large scale profiling of the transcriptome (Casamassimi et al 2017).…”
Section: Introductionmentioning
confidence: 99%
“…These class-specific estimates of RNA abundance indicate that ∼90% of the human transcriptome by mass is composed of rRNA, while the highest number of molecules per cell (MPC) is attributed to tRNA (Waldron and Lacroute 1975;Wolf and Schlessinger 1977). Other methods such as reverse transcription quantitative PCR (RT-qPCR) (Ginzinger 2002;Shakeel et al 2017), digital PCR (dPCR) (Whale et al 2012;Hayden et al 2013;Witwer et al 2013;Morley 2014;Sager et al 2015), and in situ hybridization (e.g., FISH) (Vera et al 2016) are also being used for RNA quantification, but their use remains limited to a relatively low number of RNAs and they are rarely utilized for comparisons between different classes of RNA. More recently, transcriptome sequencing has become the most frequently used method for large scale profiling of the transcriptome (Casamassimi et al 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Particular interest in oncology is focused on the field of transcriptomics for the identification and quantification of the RNA in cells, tissues, or biological fluids, representing a powerful tool for the assessment of specific biological activities [52]. In a single RNA-Seq experiment, it is possible to investigate, not only gene expression, but also alternative splicing [53], novel transcripts [54,55], allele specific expression [56], gene fusions [57], and genetic variations [58,59].…”
Section: Methodologiesmentioning
confidence: 99%
“…Whereas commercial systems are available to measure ET emission by plants in closed environments such as storage packages or boxes (Caprioli and Quercia, 2014;Tolentino et al, 2018), analysis of plant hormones in plant tissues requires cutting edge laboratory equipment (Novak et al, 2017) and highly skilled analysts. Polymerase chain reaction (PCR) is standard in detection of plant pathogens (Lau and Botella, 2017) and Reverse Transcriptase (RT) PCR is a frequently used tool in human medicine to detect the expression of critical genes, e.g., in cancer diagnosis (Sager et al, 2015). To my knowledge, up to date no RNA-based tools are available for routine determination of internal quality of plant products such as cuttings.…”
Section: Physiological Outputsmentioning
confidence: 99%